Oct 27, 2025 07:07AM
Aug 11, 2025 01:20AM
Aug 6, 2025 11:34AM
Nov 5, 2024 07:05AM
Nov 5, 2024 07:00AM
Aug 8, 2023 04:01PM
Jul 17, 2023 09:00AM Ligand Pharma (LGND) Offers $15M to Acquire Assets of Novan (NOVN)
Jul 17, 2023 08:59AM
Jun 12, 2023 06:52AM
Jun 8, 2023 07:00AM
May 15, 2023 06:45AM
Mar 30, 2023 06:32AM
Mar 30, 2023 06:30AM
Mar 30, 2023 06:30AM Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
Mar 8, 2023 09:00AM
Mar 8, 2023 09:00AM
Jan 18, 2023 08:05AM
Jan 18, 2023 08:05AM
Jan 11, 2023 01:00PM
Jan 6, 2023 08:01AM
Jan 6, 2023 08:00AM Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Jan 6, 2023 08:00AM
Dec 21, 2022 08:01AM
Dec 21, 2022 08:00AM
Dec 21, 2022 08:00AM
Dec 2, 2022 08:00AM
Dec 2, 2022 08:00AM
Dec 1, 2022 09:00AM Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
Dec 1, 2022 09:00AM
Nov 14, 2022 07:00AM
Nov 14, 2022 07:00AM
Nov 7, 2022 09:00AM
Nov 7, 2022 09:00AM
Oct 21, 2022 08:35AM
Oct 21, 2022 08:35AM EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference®
Oct 21, 2022 08:35AM
Oct 21, 2022 08:35AM
Oct 14, 2022 08:30AM
Oct 14, 2022 08:30AM
Sep 15, 2022 08:00AM
Sep 15, 2022 08:00AM
Aug 11, 2022 06:30AM Novan Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 11, 2022 06:30AM
Aug 4, 2022 09:05AM
Aug 4, 2022 09:05AM
Jul 19, 2022 08:34AM
Jul 19, 2022 08:30AM
Jul 19, 2022 08:30AM
Jul 13, 2022 11:40AM Novan (NOVN) Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology
Jul 13, 2022 11:38AM

1,155,049 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All